Announcement of European Medicines Agency priorities for adverse drug reaction research

Author (Corporate)
Series Title
Series Details 4.8.09
Publication Date 04/08/2009
Content Type

At its plenary meeting on 19 March 2009, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted its 2010 priorities for drug safety research based on recommendations from the CHMP’s Pharmacovigilance Working Party.

Source Link Link to Main Source http://www.emea.europa.eu/pdfs/human/phv/49762409en.pdf
Subject Categories ,
Countries / Regions